Dr. Robert D. Steiner, MD
Medical Genetics (Clinical Genetics (M.D.) Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Genetics (M.D.) Physician primary
WI license 61440-20 -
Clinical Biochemical Genetics Physician
WI license 61440-20 -
Pediatrics Physician
WI license 61440-20
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 3 companies reported 25 payments worth $23,191 in total to this clinician.
| Mirum Pharmaceuticals, Inc. | $14,933 |
|---|---|
| Amgen Inc. | $8,233 |
| Orchard Therapeutics North America | $25.10 |
| Consulting Fee | $18,731 |
|---|---|
| Travel and Lodging | $3,138 |
| Food and Beverage | $908 |
| Education | $414 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Mirum Pharmaceuticals, Inc. Sep 8, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $5,063 |
| Amgen Inc. Nov 11, 2025 | Consulting Fee PROCYSBI · Inflammation/Rare Disease | $5,063 |
| Mirum Pharmaceuticals, Inc. Jun 30, 2025 | Consulting Fee CHOLBAM · Rare Disease | $2,700 |
| Mirum Pharmaceuticals, Inc. Sep 1, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $1,519 |
| Mirum Pharmaceuticals, Inc. Apr 1, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $1,350 |
| Amgen Inc. Nov 11, 2025 | Consulting Fee PROCYSBI · Inflammation/Rare Disease | $1,350 |
| Amgen Inc. Oct 23, 2025 | Travel and Lodging PROCYSBI · Inflammation/Rare Disease · travel to Rosemont, IL · in-kind | $1,102 |
| Mirum Pharmaceuticals, Inc. Aug 1, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $1,013 |
| Mirum Pharmaceuticals, Inc. Jun 30, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Chicago, IL | $844 |
| Mirum Pharmaceuticals, Inc. Jul 1, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $675 |
All 17 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Nov 11, 2025 | Consulting Fee PROCYSBI · Inflammation/Rare Disease | $5,063 |
| Amgen Inc. Nov 11, 2025 | Consulting Fee PROCYSBI · Inflammation/Rare Disease | $1,350 |
| Amgen Inc. Nov 11, 2025 | Travel and Lodging PROCYSBI · Inflammation/Rare Disease · travel to Chicago, IL | $84.00 |
| Amgen Inc. Oct 23, 2025 | Travel and Lodging PROCYSBI · Inflammation/Rare Disease · travel to Rosemont, IL · in-kind | $1,102 |
| Amgen Inc. Oct 23, 2025 | Travel and Lodging PROCYSBI · Inflammation/Rare Disease · travel to Rosemont, IL · in-kind | $272 |
| Mirum Pharmaceuticals, Inc. Sep 8, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $5,063 |
| Mirum Pharmaceuticals, Inc. Sep 8, 2025 | Travel and Lodging CHOLBAM; CTEXLI · Rare Disease · travel to KYOTO, Japan | $448 |
| Mirum Pharmaceuticals, Inc. Sep 8, 2025 | Education CHOLBAM; CTEXLI · Rare Disease | $414 |
| Mirum Pharmaceuticals, Inc. Sep 8, 2025 | Travel and Lodging CHOLBAM; CTEXLI · Rare Disease · travel to KYOTO, Japan | $70.00 |
| Mirum Pharmaceuticals, Inc. Sep 1, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $1,519 |
| Mirum Pharmaceuticals, Inc. Aug 1, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $1,013 |
| Mirum Pharmaceuticals, Inc. Jul 1, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $675 |
| Mirum Pharmaceuticals, Inc. Jun 30, 2025 | Consulting Fee CHOLBAM · Rare Disease | $2,700 |
| Mirum Pharmaceuticals, Inc. Jun 30, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Chicago, IL | $844 |
| Mirum Pharmaceuticals, Inc. Jun 30, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Chicago, IL | $236 |
| Mirum Pharmaceuticals, Inc. Jun 30, 2025 | Travel and Lodging CHOLBAM · Rare Disease · travel to Chicago, IL | $81.95 |
| Mirum Pharmaceuticals, Inc. Apr 1, 2025 | Consulting Fee CHOLBAM; CTEXLI · Rare Disease | $1,350 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.